ALZHEIMER’S DISEASE: Molecular Understanding Predicts Amyloid-Based Therapeutics

22/04/2008

¹Harvard Medical School and Brigham and Women’s Hospital, Boston, Massachusetts 02115 ²Elan Pharmaceuticals, South San Francisco, California 94080

2003

Autores: Dennis J. Selkoe¹ and Dale Schenk²

Datos de publicación: Volumen 43, Páginas 545-584; Abril, 2003

Publicación: Volumen 43, Páginas 545-584; Abril, 2003